How Nanotechnology (Nanomedicine) Changing Healthcare Industry
Nanotechnology is among the most developing technologies in the present scenario. Nanotechnology is a term used when technical improvements occur at 0.1 to 100 nm scale. Nanomedicine is a field of nanotechnology that includes medicine development at the molecular level for prevention, diagnosis, treatment of diseases, and even redevelopment of tissues and organs. Hence, it aids in preserving and advances human health. Nanomedicine provides a remarkable solution for numerous life-threatening conditions such as Parkinson, Alzheimer's, cancer, diabetes, blood-related diseases, lungs, orthopedic problems, neurological, and cardiovascular system.
Healthcare nanotechnology (nanomedicine) industry is anticipated to grow in the forecast period owing to driving factors such as better regulatory framework, rising technological and research funding, and constant increase in the occurrence of chronic diseases like obesity, cancer, kidney disorder, diabetes, and orthopedic conditions. Moreover, increasing government support and awareness of nanomedicine applications are also offering opportunities in the industry growth during the forecast period.
In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Sanofi
- Abbott
- Pfizer, Inc.
- CombiMatrix Corporation
- GE Healthcare
- Celgene Corporation
- Johnson & Johnson Services, Inc.
- Luminex Corporation
- Merck & Company, Inc.
- Nanosphere, Inc.
The report analyzes factors affecting healthcare nanotechnology (nanomedicine) market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the healthcare nanotechnology (nanomedicine) market in these regions.